Arax Advisory Partners’s Mead Johnson Nutrition Company MJN Stock Holding History

Arax Advisory Partners’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-45	Closed	-$4K	–	546
2017 Q1	$4K	Sell	45 -14	-24%	-$1.15K	﹤0.01%	385
2016 Q4	$4K	Buy	+59	New	+$4.4K	﹤0.01%	393

Other funds holding MJN

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return

Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return

Envestnet Asset Management

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Arax Advisory Partners's MJN Position: Q2 2017 in Review

Arax Advisory Partners sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 45 shares — an estimated $4K sold.

Arax Advisory Partners first reported a position in MJN in Q4 2016 and held it in 2 quarters. The position peaked at $4K in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

Arax Advisory Partners reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
Arax Advisory Partners sold 45 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $4K.
Arax Advisory Partners first reported a position in Mead Johnson Nutrition Company in Q4 2016 and held it in 2 quarters.
Arax Advisory Partners's Mead Johnson Nutrition Company position peaked at $4K in Q1 2017.
7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Arax Advisory Partners's 13F filing for Q2 2017, filed 14 Aug 2017.